Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment

byiShook Opinion
Oct 15, 2024 - 20:00

Share

Novocure stock rocketed late Tuesday after the FDA signed off on its treatment for patients with metastatic lung cancer. The post Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment appeared first on Investor's Business Daily.

Novocure stock rocketed late Tuesday after the FDA signed off on its treatment for patients with metastatic lung cancer.

The post Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment appeared first on Investor's Business Daily.